Jay Redei

Prior to joining Crawford, Dr. Redei gained expertise with a dual background in medicine and computer science.
His interest and experience have been centered around the converging life sciences and IT industries since 1986.
His scientific expertise covers a number of key technologies in this emerging field of convergence, including bioinformatics applications for DNA profiling, neural networks, pattern recognition, analysis of high-dimensional data, and nanomaterials.
Dr. Redei brings years of domain experience in the global bio-pharmaceutical industry, where he held positions in software engineering, IT management and operations.
He has worked on high-profile drug development programs for clients such as Merck, Pfizer, Eli Lilly & Company, Hoffmann-La Roche, and Genetics Institute.
More recently, he has been involved in the private equity sector, as a founding partner of a $100 million German-American venture fund focusing on early-stage Internet, IT, communications and bioinformatics opportunities.
He has helped launch a number of ventures in the life sciences field and serves in an advisory capacity to several private equity and biomedical technology firms.
Previously, Dr. Redei was in senior management at PAREXEL International Corporation, one of the world's largest pharmaceutical outsourcing providers and also an Assistant Professor on the faculty of the UCSF School of Medicine.
Dr. Redei received his M.D.
degree from the University Of Bonn, Germany, and concurrently completed a Ph.D.
in Applied Neuroinformatics, Magna Cum Laude at the same institution.
He has authored more than 50 scientific papers and has received scientific awards from the European Association of Radiology and from Pfizer Pharmaceuticals.
He resides in Silicon Valley, California.